Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Opus Genetics, Inc. (IRD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Opus Genetics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1228627.
Total stock buying since 2015: $509,874.
Total stock sales since 2015: $9,351,418.
Total stock option exercises since 2015: $583,041.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 4,000,000 | $8,600,000 | 0 | $0 |
| 2024 | 155,500 | $200,066 | 0 | $0 | 0 | $0 |
| 2022 | 30,000 | $61,124 | 0 | $0 | 0 | $0 |
| 2021 | 42,881 | $188,509 | 0 | $0 | 0 | $0 |
| 2020 | 53,189 | $0 | 0 | $0 | 0 | $0 |
| 2019 | 95,000 | $60,175 | 0 | $0 | 4,000 | $0 |
| 2018 | 0 | $0 | 0 | $0 | 10,250 | $0 |
| 2017 | 0 | $0 | 250,000 | $175,500 | 250,000 | $77,500 |
| 2015 | 0 | $0 | 631,928 | $575,918 | 631,928 | $505,541 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-12 | 0 | $0 | 4,000,000 | $8,600,000 | 0 | $0 |
| 2024-11 | 110,000 | $110,964 | 0 | $0 | 0 | $0 |
| 2024-05 | 8,500 | $14,952 | 0 | $0 | 0 | $0 |
| 2024-03 | 37,000 | $74,150 | 0 | $0 | 0 | $0 |
| 2022-05 | 30,000 | $61,124 | 0 | $0 | 0 | $0 |
| 2021-12 | 8,250 | $30,112 | 0 | $0 | 0 | $0 |
| 2021-11 | 2,000 | $7,000 | 0 | $0 | 0 | $0 |
| 2021-09 | 32,631 | $151,397 | 0 | $0 | 0 | $0 |
| 2020-11 | 53,189 | $0 | 0 | $0 | 0 | $0 |
| 2019-02 | 0 | $0 | 0 | $0 | 4,000 | $0 |
| 2019-01 | 95,000 | $60,175 | 0 | $0 | 0 | $0 |
| 2018-02 | 0 | $0 | 0 | $0 | 10,250 | $0 |
| 2017-04 | 0 | $0 | 250,000 | $175,500 | 250,000 | $77,500 |
| 2015-01 | 0 | $0 | 631,928 | $575,918 | 631,928 | $505,541 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-09 | Foundation Fighting Blindness, Inc. (Director) | Sale | 4,000,000 | 2.15 | 8,600,000 |
| 2024-11-21 | Yerxa Benjamin R (President) | Buy | 10,000 | .98 | 9,830 |
| 2024-11-18 | Magrath George (Chief Executive Officer) | Buy | 9,706 | 1.02 | 9,938 |
| 2024-11-15 | Magrath George (Chief Executive Officer) | Buy | 90,294 | 1.01 | 91,196 |
| 2024-05-22 | Jayagopal Ashwath (Chief Scientific & Dev. Ofc.) | Buy | 3,500 | 1.76 | 6,177 |
| 2024-05-17 | Magrath George (Chief Executive Officer) | Buy | 5,000 | 1.75 | 8,775 |
| 2024-03-21 | Jhaveri Nirav S. (Chief Financial Officer) | Buy | 10,000 | 2.10 | 21,000 |
| 2024-03-21 | Schachle Joseph K (Chief Operating Officer) | Buy | 2,000 | 2.05 | 4,100 |
| 2024-03-18 | Magrath George (Chief Executive Officer) | Buy | 25,000 | 1.96 | 49,050 |
| 2022-05-20 | Sooch Mina (President and CEO) | Buy | 12,500 | 2.02 | 25,300 |
| 2022-05-20 | Manuso James S J | Buy | 5,000 | 1.99 | 9,950 |
| 2022-05-19 | Sooch Mina (President and CEO) | Buy | 12,500 | 2.07 | 25,874 |
| 2021-12-13 | Pepose Jay | Buy | 8,250 | 3.65 | 30,112 |
| 2021-11-18 | Manuso James S J | Buy | 2,000 | 3.50 | 7,000 |
| 2021-09-13 | Pepose Jay | Buy | 12,631 | 4.75 | 59,997 |
| 2021-09-02 | Benton Susan | Buy | 20,000 | 4.57 | 91,400 |
| 2020-11-19 | Ainsworth Sean | Buy | 8,865 | .00 | 0 |
| 2020-11-19 | Sooch Mina (President and CEO) | Buy | 11,524 | .00 | 0 |
| 2020-11-19 | Gallagher Cam | Buy | 8,865 | .00 | 0 |
| 2020-11-19 | Rodgers Richard J | Buy | 17,730 | .00 | 0 |
| 2020-11-19 | Manuso James S J | Buy | 4,434 | .00 | 0 |
| 2020-11-19 | Meyer Alan R | Buy | 1,771 | .00 | 0 |
| 2019-02-28 | Nolan Lisa (Chief Business Officer) | Option Ex | 1,625 | .00 | 0 |
| 2019-02-28 | Benaim Ely (Chief Medical Officer) | Option Ex | 2,375 | .00 | 0 |
| 2019-01-31 | Beever Charles | Buy | 10,000 | .64 | 6,380 |
| 2019-01-30 | Nolan Lisa (Chief Business Officer) | Buy | 20,000 | .65 | 12,960 |
| 2019-01-29 | Price Ben Gil | Buy | 15,000 | .61 | 9,135 |
| 2019-01-29 | Swirsky Douglas J (President and CEO) | Buy | 50,000 | .63 | 31,700 |
| 2018-02-28 | Nolan Lisa (Chief Business Officer) | Option Ex | 1,625 | .00 | 0 |
| 2018-02-28 | Benaim Ely (Chief Medical Officer) | Option Ex | 2,375 | .00 | 0 |
| 2018-02-28 | Suzdak Peter David (Chief Executive Officer) | Option Ex | 6,250 | .00 | 0 |
| 2017-04-10 | Ahn Chang Ho | Sale | 250,000 | .70 | 175,500 |
| 2017-04-10 | Ahn Chang Ho | Option Ex | 250,000 | .31 | 77,500 |
| 2015-01-12 | Jeong Tae Heum (Chief Financial Officer) | Sale | 49,800 | .91 | 45,517 |
| 2015-01-12 | Jeong Tae Heum (Chief Financial Officer) | Option Ex | 49,800 | .80 | 39,840 |
| 2015-01-12 | Ahn Chang Ho | Sale | 48,444 | .91 | 44,277 |
| 2015-01-12 | Ahn Chang Ho | Option Ex | 48,444 | .80 | 38,755 |
| 2015-01-09 | Jeong Tae Heum (Chief Financial Officer) | Sale | 188,690 | .92 | 172,651 |
| 2015-01-09 | Jeong Tae Heum (Chief Financial Officer) | Option Ex | 188,690 | .80 | 150,952 |
| 2015-01-09 | Ahn Chang Ho | Sale | 186,212 | .92 | 170,570 |
| 2015-01-09 | Ahn Chang Ho | Option Ex | 186,212 | .80 | 148,969 |
| 2015-01-08 | Jeong Tae Heum (Chief Financial Officer) | Sale | 78,782 | .90 | 70,903 |
| 2015-01-08 | Jeong Tae Heum (Chief Financial Officer) | Option Ex | 78,782 | .80 | 63,025 |
| 2015-01-08 | Ahn Chang Ho | Sale | 80,000 | .90 | 72,000 |
| 2015-01-08 | Ahn Chang Ho | Option Ex | 80,000 | .80 | 64,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of IRD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Opus Genetics, Inc. (symbol IRD, CIK number 1228627) see the Securities and Exchange Commission (SEC) website.